Latest News for: obstructive sleep apnea

Edit

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea U.S. Commercialization Officially Launched (Form 6-K) (Nyxoah SA)

Public Technologies 11 Aug 2025
Obstructive Sleep Apnea ... NYXH) ("Nyxoah" or the "Company"), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the U.S.
Edit

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Pharmiweb 08 Aug 2025
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea ... Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea.
Edit

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea (Nyxoah SA)

Public Technologies 08 Aug 2025
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea ... alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the U.S.
Edit

Apnimed Reports Positive Topline Results from Second Phase 3 Trial of AD109, Reinforcing Potential of First Oral Pill for Obstructive Sleep Apnea

PR Newswire 23 Jul 2025
AD109 is designed to be the first pharmacological treatment to improve oxygenation during sleep by directly addressing the neuromuscular root cause of upper airway collapse in people with obstructive sleep apnea ... About Obstructive Sleep Apnea.
Edit

Obstructive Sleep Apnea Clinical Trial Pipeline Expands As 12+ Companies Driving Innovation In OSA Therapeutics Delveinsight

MENA FN 16 Jul 2025
(MENAFN - GlobeNewsWire - Nasdaq) The obstructive sleep apnea (OSA) market is being propelled by the rapid evolution of early detection and diagnostic tools. Technologies like home sleep apnea ... .
Edit

Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics ...

Nasdaq Globe Newswire 16 Jul 2025
The obstructive sleep apnea (OSA) market is being propelled by the rapid evolution of early detection and diagnostic tools ... The obstructive sleep apnea (OSA) market is being propelled by the rapid ...
Edit

First Pill For Obstructive Sleep Apnea Shows Promise In Phase 3 Study

Forbes 30 Jun 2025
The AD109 pill from Apnimed could become the first ever prescription medication specifically for the treatment of obstructive sleep apnea, a needed alternative to CPAP ... .
Edit

Inspire: Addressing Obstructive Sleep Apnea

The Brunswick News 24 Jun 2025
Obstructive sleep apnea (OSA) is more than just a ...
Edit

Obstructive Sleep Apnea Market Set for Significant Growth Through 2034, Driven by Innovative Therapeutic Developments ...

GetNews 19 Jun 2025
Obstructive Sleep Apnea Pipeline Insight provides comprehensive insights about the Obstructive Sleep Apnea pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage ...
Edit

Apnimed Announces Multiple Presentations at the Associated Professional Sleep Societies (SLEEP 2025) Annual Meeting Highlighting the Disease Burden and Current Unmet Medical Needs in Obstructive Sleep Apnea (OSA)

PR Newswire 05 Jun 2025
P-09, Poster Board #169Unmasking Obstructive Sleep Apnea ... P-09, Poster Board #171Prevalence and Unmet Need of Obstructive Sleep Apnea in the United StatesTime ... P-50, Poster Board #372Improving Obstructive Sleep Apnea Management.
Edit

The Future Of Obstructive Sleep Apnea Treatment: A Paradigm Shift Fueled By Innovation And Intelligence ...

MENA FN 30 May 2025
(MENAFN - EIN Presswire) obstructive sleep apnea CI Insights From Zepbound to AD109, pharma innovation is reshaping Obstructive Sleep Apnea. Discover key players, CI insights, and pipeline ... .
×